BLRX

BioLineRX
BLRX

Overview Fund Activity

18 hedge funds and large institutions have $3.37M invested in BioLineRX in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-10
Holders Change %
-35.71%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
3
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$152K
2
LPL Financial
2
LPL Financial
California
$69.4K
3
BAM
3
Belpointe Asset Management
Nevada
$9.44K
4
AWS
4
Atria Wealth Solutions
New York
$66.9K
5
NA
5
NewEdge Advisors
Louisiana
$3

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
SM
2
Sabby Management
Florida
$1.03M
3
ACM
3
Altium Capital Management
New York
$1.83M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$0
5
AWM
5
Apollon Wealth Management
South Carolina
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
OM
26
Opaleye Management
Massachusetts
– -$16K -417 Closed
SSA
27
Schonfeld Strategic Advisors
New York
– -$13K -355 Closed
Millennium Management
28
Millennium Management
New York
– -$12K -335 Closed
1
2